KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) FCF Margin (2020 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed FCF Margin for 6 consecutive years, with 4354.92% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 440513.0% year-over-year to 4354.92%, compared with a TTM value of 66.09% through Dec 2025, up 4733.0%, and an annual FY2025 reading of 3127.16%, down 314592.0% over the prior year.
  • FCF Margin was 4354.92% for Q4 2025 at Aurinia Pharmaceuticals, down from 60.41% in the prior quarter.
  • Across five years, FCF Margin topped out at 63.05% in Q2 2025 and bottomed at 5872.76% in Q1 2021.
  • Average FCF Margin over 5 years is 572.48%, with a median of 25.89% recorded in 2022.
  • The sharpest move saw FCF Margin surged 6975058bps in 2021, then plummeted -440513bps in 2025.
  • Year by year, FCF Margin stood at 110.76% in 2021, then soared by 133bps to 36.28% in 2022, then dropped by -14bps to 31.07% in 2023, then soared by 62bps to 50.21% in 2024, then tumbled by -8774bps to 4354.92% in 2025.
  • Business Quant data shows FCF Margin for AUPH at 4354.92% in Q4 2025, 60.41% in Q3 2025, and 63.05% in Q2 2025.